2024
Providers’ knowledge and perception of xylazine in the unregulated drug supply: a sequential explanatory mixed-methods study
Hill K, Minahan-Rowley R, Biegacki E, Heimer R, Sue K. Providers’ knowledge and perception of xylazine in the unregulated drug supply: a sequential explanatory mixed-methods study. Harm Reduction Journal 2024, 21: 148. PMID: 39148036, PMCID: PMC11328386, DOI: 10.1186/s12954-024-01052-4.Peer-Reviewed Original ResearchConceptsSequential explanatory mixed-methods studyExplanatory mixed-methods studyMixed-methods studyHealthcare providersHealthcare providers' experiencesHealthcare providers treating patientsSample of providersProviders treating patientsDrug supplyProvider experienceProvider knowledgeIn-depth interviewsImprove careSense of helplessnessConvenience sampleHealthcare educationThematic analysisInterview transcriptsQualitative phasePurposive samplingProvidersHealthcareOpioid supplyAbsence of literatureResultsSeventy-eight
2023
Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department–Initiated Buprenorphine Programs
Sue K, Chawarski M, Curry L, McNeil R, Coupet E, Schwartz R, Wilder C, Tsui J, Hawk K, D’Onofrio G, O’Connor P, Fiellin D, Edelman E. Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department–Initiated Buprenorphine Programs. JAMA Network Open 2023, 6: e2312718. PMID: 37163263, PMCID: PMC10173026, DOI: 10.1001/jamanetworkopen.2023.12718.Peer-Reviewed Original ResearchConceptsCommunity-based cliniciansOpioid use disorderEmergency departmentOUD treatmentMedication treatmentSubstance use disorders trainingUrban academic emergency departmentEffectiveness-implementation studyAcademic emergency departmentDisorder treatment settingsPerspectives of cliniciansCommunity-based treatmentCommunity-based treatment programsStaff perspectivesImplementation science frameworkBuprenorphine programTreatment cliniciansPeer navigatorsReferral sitesPromoting ActionMAIN OUTCOMEED staffBuprenorphineFocus groupsUse disorders
2022
Safety in solitude? Competing risks and drivers of solitary drug use among women who inject drugs and implications for overdose detection
Rosen J, Glick J, Zhang L, Cooper L, Olatunde P, Pelaez D, Rouhani S, Sue K, Park J. Safety in solitude? Competing risks and drivers of solitary drug use among women who inject drugs and implications for overdose detection. Addiction 2022, 118: 847-854. PMID: 36468191, PMCID: PMC10073256, DOI: 10.1111/add.16103.Peer-Reviewed Original ResearchConceptsThreat of violenceCross-sectional qualitative studyDepth interviewsHarm reduction strategiesPublic spaceOverdose riskDrug useThematic analysisQualitative studyEmergent designSocial environmentRisk environmentNaloxone possessionBaltimore CityInterviewsWWIDReduction strategiesOpioid withdrawalViolenceFatal overdoseStreet intercept